The table below shows Arcus Biosciences, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$247.00M
$258.00M
$117.00M
$112.00M
$383.00M
$78.00M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$523.00M
$448.00M
$340.00M
$288.00M
$257.00M
$159.00M
SG&A
RCUS annual revenue (10-K history)
Arcus Biosciences, Inc. reported annual revenue of $247.00M for fiscal year 2025. That is down 4.3% from $258.00M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $1.41M (FY 2017) to $247.00M. Figures come from the company's audited annual reports as filed with the SEC.
